Navigation Links
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Date:6/12/2013

THOUSAND OAKS, Calif., June 12, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the Phase 3 TRINOVA-1 trial evaluating trebananib plus paclitaxel versus placebo plus paclitaxel in recurrent ovarian cancer met its primary endpoint of progression-free survival (PFS). A statistically significant difference was observed in PFS with a 34 percent reduction in the risk of disease progression or death (HR = 0.66, 95 percent CI, 0.57, 0.77, p<0.001). The median PFS was 7.2 months in the trebananib arm versus 5.4 months in the control arm.

The primary analysis of overall survival (OS), a key secondary endpoint, is expected to mature in 2014 in line with previous guidance. Although an early imbalance of deaths favoring the control arm was observed, there was an overall favorable OS trend for trebananib in a pre-planned interim analysis.

"The TRINOVA-1 study is the first of three Phase 3 trials designed to evaluate the safety and efficacy of trebananib in patients with ovarian cancer," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen. "Angiopoietin inhibition has been a focus of research at Amgen and these results suggest that the novel biology of trebananib may offer a promising approach for patients with ovarian cancer."

In the trebananib arm, the most frequently reported adverse events were localized edema, nausea and alopecia. The rate of discontinuation of investigational product due to adverse events was 20 percent in the trebananib arm versus seven percent in the control arm.

Approximately 22,240 new cases of ovarian cancer will be diagnosed in the United States in 2013.1 More than 70 percent of women with ovarian cancer will present with advanced disease at diagnosis and up to 80 percent of them will exp
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
2. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
3. Amgen And Astellas Announce Japan Alliance
4. Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
7. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
8. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
9. Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
10. Amgens First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
11. Amgen Announces Webcast of 2013 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015  Trovagene, Inc., (NASDAQ: ... today that clinical data presented at the 2015 ... urine-based Precision Cancer Monitoring ℠ (PCM) platform ... of EGFR T790M mutations in metastatic ... of EGFR T790M Mutation in Urinary Circulating Tumor ...
(Date:4/17/2015)... 2015 Steven Rash , the CEO of ... operating subsidiary American Seed & Oil Company, presented the ... yesterday in New York City.  Mr. Rash,s presentation featured ... Seed & Oil Company has recently announced the ... Seed Foods , the EpiVape , and ...
(Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ) has ... Pharma in 2014 - a Perspective of Mental Health ... offering. For the first time, in 2014, ... of the pharmaceutical industry held by patient groups with ... patient organisations representing all therapy areas. - ...
Breaking Medicine Technology:Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
... , , MINNEAPOLIS and ST. PAUL, Minn., Nov. 16 ... connected with friends, keeping up with school, and simply passing time ... More and more patients are relying on technology to help, from ... But when that technology fails, it can bring added stress to ...
... , WASHINGTON, Nov. 16 Despite ... market has increased approximately 15 percent in the past two ... Deloitte Center for Health Solutions. Retail clinic market growth, however, ... and will accelerate above 30 percent from 2013-2014, according to ...
Cached Medicine Technology:Children's Hospitals and Clinics of Minnesota Teams With Geek Squad to Open First Ever In-Hospital Precinct 2Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 2Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 3Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 4
(Date:4/17/2015)... April 17, 2015 Enthusiasts of gourmet cuisine ... Saturday, April 25, 2015. The event will be held in ... Food (201 Monroe Ave NW, Grand Rapids, MI 49503) and ... West Michigan area. Patrons are encouraged to savor the food ... fun. , This year’s event will feature seven chefs, including:, ...
(Date:4/17/2015)... York, New York (PRWEB) April 17, 2015 ... that allege this class of prescription medications ... a heart attack, stroke or other life-threatening cardiovascular ... underway in U.S. District Court, Northern District of ... by the U.S. Judicial Panel on Multidistrict Litigation ...
(Date:4/17/2015)... 2015 The American College of Traditional Chinese Medicine ... Day on April 29. The event will be held from 11 ... 555 DeHaro St. in San Francisco, CA. , The agenda for ... at the DeHaro campus (room F), 11:10 a.m. – Introduction ... – Light lunch with current students, faculty and staff, 1 p.m. ...
(Date:4/17/2015)... With Dr. Taj Haynes at the ... the last four years providing residents of Concord, North ... general cleanings to dental implants and Invisalign installations. On ... new office in North Charlotte. , The Charlotte office ... office, including denture fittings, cosmetic procedures, and gum disease ...
(Date:4/17/2015)... NY (PRWEB) April 17, 2015 ... formulated to polish and perfect facial skin with ... Palm seeds and blend of energizing botanicals. This ... skin cells that cause breakouts and inhibit penetration ... Ingredients: , Ecuadorian Ivory Palm Seeds, This uncommon ...
Breaking Medicine News(10 mins):Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4Health News:American College of Traditional Chinese Medicine Hosts Open House 2Health News:Mario Badescu Skin Care Launches Botanical Exfoliating Scrub 2
... drug that kills chronic leukemia cells., The drug targets a ... leukemia cells., This study showed unexpectedly that CD37 helps regulate ... and how it might be improved. COLUMBUS, ... role for a molecule on the surface of the immune ...
... their seventies who exercise and eat healthy amounts of fruits ... published in the Journal of the American Geriatrics Society ... Johns Hopkins University studied 713 women aged 70 to 79 ... Studies. This study was designed to evaluate the causes and ...
... Granada has concluded that most immigrant women who give ... psychological treatment after giving birth to help them overcome ... or psychoticism. These disorders are caused by "the stress ... This is a very stressful moment in women,s life ...
... , WEDNESDAY, May 30 (HealthDay News) -- ,The ancient ... syndrome, a small new study suggests. Metabolic syndrome is ... (a type of fat found in the blood), high fasting ... the risk of diabetes and heart disease. Bloodletting was ...
... 13 for SLEEP 2012, the premier event for sleep ... with the best clinical practices. SLEEP 2012, the 26th ... is being held at the John B. Hynes Veterans Memorial ... exhibition hall focused solely on sleep medicine and sleep research. ...
... HealthDay Reporter , TUESDAY, May 29 (HealthDay News) -- ... more likely to eat better and watch less TV if ... and get reminders from coaches. It,s not clear how ... why it might work, but the study lead author said ...
Cached Medicine News:Health News:Researchers identify a 'life-and-death' molecule on chronic leukemia cells 2Health News:Exercise and a healthy diet of fruits and vegetables extends life expectancy in women in their 70s 2Health News:Immigrant women giving birth in Spain suffer 'great stress,' a study warns 2Health News:Could Bloodletting Ease Heart Risks for the Obese? 2Health News:SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston 2Health News:Cash, Coaching May Boost Healthy Living 2Health News:Cash, Coaching May Boost Healthy Living 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: